About 800 reports

  • 2.8.3 TARGETED THERAPIES
  • summarizes the treatment algorithm for patients diagnosed

Colorectal Cancer Therapeutics in Asia-Pacific Markets to 2024 - Launch of Premium Targeted Therapies and Increasing Prevalence to Drive the Market Summary Many countries are facing the challenge of an aging population, and there will be an increased number of people aged 50 and over – a high-risk...

  • Cancer
  • Targeted Therapy
  • World
  • Market Size
  • Merck & Co., Inc.
  • Launch of Targeted Therapies and Immuno-Oncology Agents to Address Unmet Need in TNBC and Further Drive Market Growth
  • 6.5.2 ANNUAL COST OF THERAPY

Breast Cancer Therapeutics in Asia-Pacific Markets to 2024 - Growth Driven by Increasing Uptake of Targeted Therapies and Rising Prevalence Summary Breast cancer is a malignant neoplasm that begins in the breast tissue, which is made up of glands for milk production, called lobules, and the ducts...

  • Targeted Therapy
  • World
  • Market Size
  • AstraZeneca PLC
  • Roche Group
  • 2.8.4 TARGETED THERAPIES
  • Diagnosed prevalence and treated pool for targeted therapies to increase over the forecast period

Breast Cancer Therapeutics in Southeast Asia Markets to 2022 - Increasing Prevalence and Usage of Premium Targeted Therapies to Drive the Market Summary Breast cancer is a malignant neoplasm that begins in the breast tissue, which is made up of glands for milk production called lobules and the ducts that connect the lobules...

  • Targeted Therapy
  • Southeast Asia
  • World
  • Market Size
  • Novartis AG
  • NEW THERAPIES INCREASE MARKET SEGMENTATION AND DIVERSIFY TREATMENT
  • 6.3.2 ANNUAL COST OF THERAPY

One such limitation is the lack of diversity in targeted therapies.

  • Targeted Therapy
  • World
  • AstraZeneca PLC
  • Novartis AG
  • Roche Group
  • 2.7.3.2 Targeted Therapy
  • 7.2.2 DEALS BY STAGE OF DEVELOPMENT AND VALUE

Global Hematological Cancers Market to 2022 - Commercially Successful Targeted Therapies and Large, Innovative Pipeline to Drive Market Summary Hematological malignancies are a class of cancer that affect the blood, lymph nodes and bone marrow. They include numerous forms of leukemia, lymphoma and myeloma. Hematological...

  • Targeted Therapy
  • World
  • Market Size
  • Celgene Corporation
  • Novartis AG
  • 3.2 HER2-Targeted Therapy
  • 6.7 Japan

Gastric Cancer Therapeutics in Asia-Pacific Markets to 2022 - Growth Driven by Increasing Prevalence and Launch of Targeted Therapies Summary Gastric cancer is characterized by the formation of malignant cells in the inner lining of the stomach, and is the fifth most common cancer globally. Due to its indolent nature it...

  • Targeted Therapy
  • World
  • Market Size
  • AstraZeneca PLC
  • Roche Group

Targeted Therapies in Asthma: KOL Insight [2018] ##.

  • Targeted Therapy
  • Therapy
  • North America
  • United Kingdom
  • United States

Targeted Therapies in Asthma: KOL Insight: Update Bulletin [April 2017] This edition presents key opinion leader (KOL) views on recent developments in the targeted asthma treatment market Topics covered include; GlaxoSmithKline’s (GSK) presentation of new data at

  • Monoclonal Antibody
  • Salicylic Acid
  • Targeted Therapy
  • Therapy
  • World
  • BCMA TARGETED THERAPIES: DEVELOPMENT PIPELINE,
  • BCMA TARGETED THERAPIES: DISTRIBUTION BY INDICATION

INTRODUCTION B-cell maturation antigen (BCMA), an important biomarker of the B-cells, has emerged as a promising therapeutic target for the treatment of multiple myeloma and other hematological malignancies. The antigen is universally expressed on the surface of multiple myeloma cells. The research focus shifted towards BCMA...

  • Targeted Therapy
  • United States
  • Affimed Therapeutics AG
  • Amgen Inc.
  • Celgene Corporation

Targeted Therapies in Asthma - 2017 ##.

  • Monoclonal Antibody
  • Respiratory Treatment
  • Targeted Therapy
  • Therapy
  • United States

Targeted Therapies In Asthma: Update Bulletin [April 2016] This edition presents key opinion leader (KOL) views on recent developments in the asthma market, including the clinical role of Nucala (mepolizumab; GSK) the prospects for Teva’s recently approved Cinqair (reslizumab) and

  • Monoclonal Antibody
  • Targeted Therapy
  • Therapy
  • 6.1.2 TARGET THERAPY
  • Cancer Therapy Market: Revenue in USD million, by Target Therapy, Global, 2015-2023

The global cancer therapy market is expected to register a CAGR of 6.5% during the forecast period, 2018 to 2023. North America dominates the market, due to growing prevalence of cancer diseases and rapid adoption of new therapy and novel drugs in the region. High Prevalence and Incidence of Cancer Disease Worldwide Cancer is...

  • Targeted Therapy
  • United States
  • Amgen Inc.
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • 4 MAJOR MAB-TARGETING THERAPY AREAS
  • 2.1 INITIAL MAB DEVELOPMENT

Monoclonal Antibodies - Global Trends in the Competitive, Technological and R&D Landscape Summary Antibodies, otherwise known as immunoglobulins (Ig), are large, Y-shaped glycoproteins produced by immune cells in response to pathogens such as bacteria and viruses. They consist of two large heavy polypeptide chains and...

  • Targeted Therapy
  • AbbVie Inc.
  • Bristol-Myers Squibb Company
  • Genentech, Inc.
  • Johnson & Johnson
  • Targeted Therapy Drug Import
  • Targeted Therapy Drug

This study focuses on China’s Breast Cancer Treatment Drug industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the...

  • Targeted Therapy
  • China
  • ACON Biotech Co., Ltd
  • AstraZeneca China Inc.
  • Bayer Schering Pharmaceutical Co., Ltd
  • Aromatase Inhibitors (Targeted Therapy Drug)
  • Aromatase Inhibitors (Targeted Therapy Drug)

China’s demand for Breast Cancer Treatment Drug has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export,...

  • Targeted Therapy
  • China
  • AstraZeneca China Inc.
  • Bayer Schering Pharmaceutical Co., Ltd
  • Beijing Novartis Pharma Ltd
  • MOST PRESCRIBED TARGETED THERAPIES FOR MCRC, BY SEGMENT IN THE 8MM, 2016
  • STIVARGA SWOT ANALYSIS, 2016

PharmaPoint: Colorectal Cancer - Global Drug Forecast and Market Analysis to 2025 Summary Colorectal Cancer (CRC) Market, considering the sales of both branded treatments and generic chemotherapy, is expected to experience a moderate growth between 2015 and 2025. The main drivers of growth will be the expected increased...

  • Targeted Therapy
  • Eli Lilly & Co.
  • Merck & Co., Inc.
  • Roche Group
  • Taiho Pharmaceutical Co., Ltd.
  • Targeted Therapy Drug Sales Volume (million Yuan)
  • Targeted Therapy Drug Sales Volume by Drugs Classification in 2017(percent)

This study focuses on China’s Kidney Cancer Treatment Drugs industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the...

  • Targeted Therapy
  • China
  • Demand
  • AstraZeneca China Inc.
  • Bayer Schering Pharmaceutical Co., Ltd
  • Targeted Therapy Drug Sales Volume (million Yuan)
  • Targeted Therapy Drug Sales Volume by Drugs Classification in 2017(percent)

China’s demand for Kidney Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports,...

  • Targeted Therapy
  • China
  • Demand
  • AstraZeneca China Inc.
  • Bayer Schering Pharmaceutical Co., Ltd
  • GROWING DEMAND FOR TARGETED THERAPIES
  • LUNG CANCER THERAPEUTICS MARKET IN AMERICAS

About Lung Cancer Therapeutics Lung cancer is a common cause of mortality and morbidity in both developed and developing countries. Smoking is a major cause of lung cancer, though it also occurs in non-smokers. Lung cancer can be categorized into two major types, namely NSCLC and SCLC. NSCLC is the commonest type of lung cancer and constitutes...

  • Targeted Therapy
  • AstraZeneca PLC
  • Celgene Corporation
  • Eli Lilly & Co.
  • Hoffmann-La Roche Inc.
  • Launch of Novel Targeted Therapies and Biosimilars to Drive Market Growth
  • B) Aggregate deal value by molecule type

Psoriasis Therapeutics in Asia-Pacific Markets to 2024 - Increasing Prevalence, Advent of Novel Biologics and Pipeline Drugs to Drive the Market Summary Psoriasis is a chronic, autoimmune, relapsing, inflammatory disease triggered by deregulated thymus-derived cells (T cells), resulting in inflammation...

  • Targeted Therapy
  • World
  • Market Size
  • AbbVie Inc.
  • Janssen Biotech, Inc.
  • 2.8.3 TARGETED THERAPIES
  • 3.3 Epidermal Growth Factor Receptor Targeted Therapies

Head and Neck Cancer Therapeutics in Asia-Pacific Markets to 2023 - Launch of Premium Immunotherapies and Increasing Prevalence to Drive the Market Summary Head and neck squamous cell carcinoma is the sixth most common cancer, and its incidence is growing. The term head and neck cancer (HNC) refers...

  • Targeted Therapy
  • World
  • Market Size
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • Entry of Novel Targeted Therapies and Triple-Combination Therapies to Expand Treatment Options
  • Pipeline Analysis

COPD Therapeutics in Asia-Pacific Markets to 2023 - Growth Driven by Rising Prevalence, Growing Awareness and Expected Launch of Novel Therapies Summary Chronic obstructive pulmonary disease (COPD) is a term that refers to a large group of lung diseases characterized by obstruction of airflow that...

  • Targeted Therapy
  • AstraZeneca PLC
  • Boehringer Ingelheim GmbH
  • GlaxoSmithKline plc
  • Novartis AG
  • TARGETED THERAPY
  • Market landscape

About Multiple Myeloma Drugs Multiple myeloma is an abnormal growth and accumulation of plasma cells in the bone marrow leading to malignancy. This can be caused by the overproduction of monoclonal immunoglobulins such as IgG, IgA, IgD, or IgE; or Bence-Jones protein. Under normal conditions, stem cells develop into B lymphocytes, mature...

  • Targeted Therapy
  • Amgen Inc.
  • Celgene Corporation
  • Novartis AG
  • Takeda Pharmaceutical Company Limited
  • OPPORTUNITY REMAINS FOR THE DEVELOPMENT OF NOVEL TARGETED THERAPIES
  • DEVELOPMENT STRATEGIES FOCUS ON IMPROVING TARGETED THERAPY OPTIONS

PharmaPoint: Non-Small Cell Lung Cancer (NSCLC) - Global Drug Forecast and Market Analysis to 2025 Summary Lung cancer is currently the most common cancer in the world, and is the most common cause of death from cancer worldwide. Of the total lung cancer incident cases, approximately 85% are the non-small cell lung cancer...

  • Targeted Therapy
  • Eli Lilly & Co.
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer Inc.
  • 2.6.3 HORMONAL THERAPIES
  • UROLOGIC ONCOLOGY, GLOBAL, ASTELLAS PHARMA INC. ANNUAL REVENUE FORECAST

Available from: http:/ / www. cancer. gov/ about-cancer/ treatment/ types/ targeted-therapies/ targeted-therapiesfact-sheet [Accessed April ##, 2016] NCI (2014c).

  • Targeted Therapy
  • World
  • Astellas Pharma Inc.
  • AstraZeneca PLC
  • Pfizer Inc.
  • Analyst View
  • Analyst View

Pergamum AB collaborated with Cadila Pharmaceuticals to develop a novel treatment for infections with a unique targeting mechanism.

  • Targeted Therapy
  • Biocon Limited
  • Mylan Inc.
  • Pfizer Inc.
  • Sandoz Inc.
  • 5.4 Global Prostate Cancer Targeted Therapy Market & Forecast
  • 4. Global Prostate Cancer - Targeted Therapy Drugs Market

Prostate Cancer remains a top priority for health systems around the world as incidence level rises, fueled by growing and aging populations. The main drivers for the prostate cancer market are the increase in the global aging population, innovation in drugs and developments in genomics and proteomics. The prostate cancer market faces some...

  • Chemotherapy
  • Targeted Therapy
  • World
  • Astellas Pharma Inc.
  • Medivation, Inc.
  • 9.6.2 MOLECULAR TARGETED THERAPIES
  • BRAF, MEK AND C-KIT TARGETED THERAPIES

PharmaPoint: Melanoma - Global Drug Forecast and Market Analysis to 2026 Summary Melanoma is the deadliest and most aggressive form of skin cancer. Melanoma is rare compared to other major cancer indications, but the incident cases are increasing because of the aging population and changes in lifestyle...

  • Targeted Therapy
  • Australia
  • Merck & Co., Inc.
  • Novartis AG
  • Roche Group
  • Targeted therapy-IR
  • Targeted therapy-IR

KOL Perspectives: IL-6 inhibitors in Rheumatoid Arthritis Summary This KOL Insight briefing focuses on perceptions of IL-6 inhibitors in rheumatoid arthritis (RA). The briefing includes analysis of KOL opinion on the following topic areas - - Current or anticipated future use of sarilumab...

  • Monoclonal Antibody
  • Targeted Therapy
  • Therapy
  • European Union
  • United States
  • 7.5 TARGETED THERAPIES FOR NON-CLEAR CELL RCC
  • BAYER SWOT ANALYSIS IN RCC, 2014

PharmaPoint: Renal Cell Carcinoma - Global Drug Forecast and Market Analysis to 2023 Summary Renal cell carcinoma (RCC) is among the 10 most frequently occurring cancers in Western countries. The RCC market is currently dominated by anti-angiogenic agents and tyrosine kinase inhibitors (TKIs) in particular, but it will...

  • Targeted Therapy
  • Eisai Co., Ltd.
  • Exelixis, Inc.
  • Pfizer Inc.
  • Roche Group